Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/1998
05/14/1998CA2270775A1 Improved intraocular irrigating solution containing a polyamine antagonist
05/14/1998CA2270619A1 Methods for promoting wound healing and treating transplant-associated vasculopathy
05/14/1998CA2270520A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998CA2270349A1 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
05/14/1998CA2270291A1 Prostate-specific kallikrein
05/14/1998CA2270153A1 Methods for identifying genes essential to the growth of an organism
05/14/1998CA2270118A1 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/14/1998CA2269665A1 Human regulator of g-protein signaling - (hrgs)
05/14/1998CA2269647A1 Human squalene epoxidase
05/14/1998CA2269646A1 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998CA2268354A1 Soluble proteins
05/14/1998CA2263199A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
05/13/1998EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
05/13/1998EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840787A2 A human edg-2 receptor homolog
05/13/1998EP0840750A1 Ha-2 antigenic peptide
05/13/1998EP0840744A1 Phosphonic acid-based cationic lipids
05/13/1998EP0840729A1 Inhibitors of phospholipase a 2?
05/13/1998EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
05/13/1998EP0840615A2 Chemokine binding protein and methods of use therefor
05/13/1998EP0840610A1 Composition comprising d-threo-methylphenidate and another drug
05/13/1998EP0840605A1 Compounds useful in the treatment of neurofibromatosis
05/13/1998EP0840603A1 Pharmaceutical composition of l-dopa ethyl ester
05/13/1998EP0840601A1 Non-allosteric gaba-a agonists for treating sleep disorders
05/13/1998EP0840575A1 Angiogenic lipid formulations
05/13/1998CN1181703A Controlled release of miotic and mydriatic drugs in the anterior chamber
05/13/1998CN1181701A Pharmaceutical compsn. containing N-chlorophenylcar-bamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses andcancers
05/12/1998US5750679 Process for obtaining pharmacologically active compounds from complex mixtures of substances
05/12/1998US5750579 Solution of disinfectant, alcohol, thickener
05/12/1998US5750571 Methods and therapeutic compositions for treating cystic fibrosis
05/12/1998US5750559 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
05/12/1998US5750519 Administering dopamine antagonist and prolactin stimulator
05/12/1998US5750495 Administering tumor necrosis factor
05/12/1998US5750493 Alpha-1-acid glycoprotein binders
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/12/1998US5750356 Method for monitoring T cell reactivity
05/12/1998US5750351 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
05/12/1998US5750146 Translucent collagen formulations with a cytotoxic drug
05/12/1998US5750141 Drug delivery to body tissue below the stratum corneum and increase local perfusion and/or concentration of the drug
05/12/1998US5750132 Adinistering extracellular, recombinant hemoglobin to treat disorders resulting from radiation, anemia, tissue ischemia
05/12/1998US5750119 Immunotherapeutic stress protein-peptide complexes against cancer
05/07/1998WO1998019165A1 A method for the identification of compounds with anxiolytic potential
05/07/1998WO1998018960A1 Process aimed at evidencing the state of a malignant cell and process for treatment
05/07/1998WO1998018947A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use
05/07/1998WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998WO1998018923A1 NOVEL flt-3 RECEPTOR AGONISTS
05/07/1998WO1998018921A1 NEUTROKINE $g(a)
05/07/1998WO1998018916A1 Human p2x purinoreceptor
05/07/1998WO1998018827A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018500A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018491A1 Methods and compositions for dietary supplementation
05/07/1998WO1998018490A1 Combinations for use in increasing the potency of a substrate for multidrug resistance related protein
05/07/1998WO1998018482A1 Use of lh-rh antagonists as diagnostic agent
05/07/1998WO1998018481A1 Combination therapy for the treatment of diabetes and obesity
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018476A1 Methods of treating or preventing cardiac arrhythmia
05/07/1998WO1998018475A1 Methods of treating or preventing cardiac arrhythmia
05/07/1998WO1998018468A1 Synergistic composition comprising rapamycin and calcitriol
05/07/1998WO1998018460A1 Integrin antagonists
05/07/1998WO1998018456A1 Protease-activated receptor 3 and uses thereof
05/07/1998WO1998018440A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin
05/07/1998WO1998018324A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
05/07/1998WO1998009618A3 Graft survival prolongation with porphyrins
05/07/1998WO1998008536A3 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
05/07/1998WO1998006841A3 Two human nsp-like proteins
05/07/1998WO1998005360A3 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes
05/07/1998WO1998005323A3 Method of regulating the female reproductive system through angiogenesis inhibitors
05/07/1998WO1997046683A3 Polynucleotides encoding secreted proteins
05/07/1998WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/07/1998DE19644994A1 Diagnostisches Mittel Diagnostic agent
05/07/1998CA2665133A1 Neutrokine .alpha.
05/07/1998CA2270375A1 Combinations for use in increasing the potency of a substrate for multidrug resistance related protein
05/07/1998CA2270373A1 Synergistic composition comprising rapamycin and calcitriol
05/07/1998CA2270345A1 Immunostimulatory nucleic acid molecules
05/07/1998CA2270223A1 Methods and compositions for dietary supplementation
05/07/1998CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2269985A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2269865A1 Process aimed at evidencing the state of a malignant cell and process for treatment
05/07/1998CA2269660A1 Combination therapy for the treatment of diabetes and obesity
05/07/1998CA2269635A1 Protease-activated receptor 3 and uses thereof
05/07/1998CA2269213A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
05/07/1998CA2268942A1 Methods of treating or preventing cardiac arrhythmia
05/07/1998CA2268940A1 Integrin antagonists
05/07/1998CA2268750A1 Human p2x purinoreceptor
05/07/1998CA2268027A1 Novel flt-3 receptor agonists
05/07/1998CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/06/1998EP0839908A2 A novel human ETS family member, ELF3
05/06/1998EP0839831A2 Single chain gonadotropin
05/06/1998EP0839155A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
05/06/1998EP0839052A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases
05/06/1998EP0839041A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts
05/06/1998EP0839039A1 Paroxetine controlled release compositions
05/06/1998EP0839033A2 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral
05/06/1998EP0839031A1 Use of a non-steroidal anti-inflammatory drug for topical and systemic treatment of acute and chronic polypoid rhinosinusitis
05/06/1998EP0839026A1 Polyether block copolymer micellar compositions for targeting biological agents
05/06/1998EP0817636A4 Cinnamoyl-c-glycoside chromone isolated from aloe barbadensis
05/06/1998EP0671908B1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers
05/06/1998CN1181014A A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
1 ... 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 ... 1151